Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00720057 · ClinicalTrials.gov registry record · Phase 3
Assessing the Analgesic Efficacy of Naproxen Sodium in Postsurgical Dental Pain.
A Phase 3 study of Toothache, sponsored by Bayer.
- Completed
- Registry status
- Phase 3
- Development phase
- 312
- Enrollment target
- 3
- Study locations
NCT00720057 is a Phase 3 study of Toothache that has completed, run by Bayer. The registered enrollment target is 312 participants, above the 61-participant average among 3 other Toothache trials with a reported enrollment target (411% higher). The trial reports 3 study locations across 2 states.
The verdict
NCT00720057, a Phase 3 study of Toothache, has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 312 participants
- Enrollment target
- 3
- Study locations
Study Summary
To evaluate the analgesic efficacy of a single, oral dose of a naproxen sodium extended-release tablet, compared to placebo in postsurgical dental pain.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Naproxen Sodium ER (BAYH6689)
Study Locations (3)
Texas
- - Austin
- - Austin
Utah
- - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 312 participants |
| Start Date | 2008-06 |
| Est. Completion | 2008-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00720057
The ClinicalTrials.gov registry entry for NCT00720057 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 312 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 61-participant average among 3 other Toothache trials with a reported enrollment target (411% higher). The listed sponsor is Bayer, which has 591 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Toothache appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00720057 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Texas, Utah.
Frequently Asked Questions
What is clinical trial NCT00720057 about?
NCT00720057 is a clinical study titled "Assessing the Analgesic Efficacy of Naproxen Sodium in Postsurgical Dental Pain.". To evaluate the analgesic efficacy of a single, oral dose of a naproxen sodium extended-release tablet, compared to placebo in postsurgical dental pain.
What is the current status of trial NCT00720057?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 312 participants. The study started on 2008-06. Estimated completion is 2008-08.
What conditions does trial NCT00720057 study?
This clinical trial studies the following conditions: Toothache.
What interventions are being tested in trial NCT00720057?
The interventions under investigation include: Placebo (DRUG), Naproxen Sodium ER (BAYH6689) (DRUG).
Who is sponsoring clinical trial NCT00720057?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00720057 being conducted?
This trial has 3 study locations across Texas, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Toothache
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.